Platelets bud from megakaryocytes in the bone marrow, and then normally circulate about 10 days in the blood. Since they are fragments of cells, they have no nucleus. But platelets do have most other cellular organelles, including microtubules, which help hold the unactivated platelet in a nice, crisp discoid shape. But most important for us are two types of secretion vesicles:
(In lab, we are looking at figure 3.2, which shows an unactivated platelet and figure 3.10b in Wheater, which shows activated platelets.)
When platelets are circulating through vessels with an intact, healthy endothelium, the platelets remain in their original, unactivated state. The absence of activating factors and the release of prostacyclin (prostaglandin I2) by the healthy endothelium supports this state.
However, when a platelet encounters a break in the endothelium, it encounters molecules that trigger its activation. One such molecule is collagen, which is characteristically found almost everywhere except inside a blood vessel. In addition, thromboxane A2, ADP and thrombin are other factors that trigger the same activation.
The following are some of the main things that happen as a platelet is activated:
QUESTION: Name three factors that not only are produced or released as a result of platelet activation but also cause platelet activation.
QUESTION: Is this an example of negative or positive feedback?
QUESTION: Some people take one "baby" aspirin a day to reduce the risk of a myocardial infarction. What molecules are affected by the aspirin?
QUESTION: Why is such a small amount of the drug effective?
The coagulation reactions tend to occur along with platelet activation. Together, the two systems form a clot.
As with platelet activation, the blood coagulation reactions are set in motion by damage to a blood vessel. One especially important factor for starting this sequence of reactions is contact of the blood with tissue factor, which is found especially in the tissue surrounding blood vessels.
In each step, an inactive protein (called a "factor") in the blood plasma is converted to an active proteolytic enzyme. The active enzyme in turn promotes the next step. Finally, prothrombin is converted to the active enzyme thrombin. But this sequence is dependent on platelets, since the surface of activated platelets is important for some of the reactions.
(Figure 12-74 in Vander shows the classical representation of the entire sequence that forms thrombin. But don't worry about the details and just focus on the above bold-faced terms. The sequence is complex and, moreover, recent schemes organize the complex of reactions in different ways. However, it is not a bad idea to take a look at the Vander figure to get a general idea about what is involved.)
Thrombin converts the blood protein fibrinogen to fibrin. Fibrinogen is a large soluble protein (with three polypeptide chains) that remains dispersed in the plasma. But after thrombin cleaves off peptides, the resulting fibrin molecules begin adhering to one another and assemble into long fibrils. Thus, fibrinogen plays two quite different roles: as "platelet glue" and as the protein that is the starting point for the formation of the long protein fibrils of a blood clot.
The blood coagulation reactions occur somewhat more slowly than platelet activation and may not be necessary to seal small breaks in the endothelium. Platelet plugs created by rapid platelet activation may be suffficient. But for larger breaks in blood vessels, the fibrin must form too. As the developing fibrils of fibrin form, they trap interspersed, activated platelets, forming a clot.
Note that the blood coagulation reactions also tend to accentuate platelet activation, for example, by releasing thrombin. Thus, both systems tend to be mutually reinforcing.
(The following assumes you have read the pertinent part of the disorders section of the handout.)